Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel G Carlson

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Neuroscience Research|December 13, 2002
Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoidNoel G Carlson
CNS Drugs|June 1, 2006
Antioxidants in multiple sclerosis: do they have a role in therapy?Noel G Carlson, John W Rose
Expert Opinion on Medical Diagnostics|March 15, 2013
Clinical biomarkers in multiple sclerosisJohn W Rose, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Vitamin D as a clinical biomarker in multiple sclerosisNoel G Carlson, John W Rose
Annals of Neurology|May 24, 2020
CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar DegenerationJohn E Greenlee, Noel G Carlson
Seminars in Neurology|July 17, 2018
Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and ImmunopathologyJon P Williams, Noel G Carlson, John E Greenlee
Current Treatment Options in Neurology|April 15, 2009
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John F Foley, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Optical coherence tomography as a biomarker in multiple sclerosisAnette Simble Fjeldstad, Noel G Carlson, John W Rose
American Journal of Physiology. Renal Physiology|April 21, 2005
P2Y2 receptor-mediated release of prostaglandin E2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD functionRujia Sun, Noel G Carlson, Andrew C Hemmert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2021
Improvement of Comorbid Psoriasis in Patients With MS Treated With NatalizumabRegina Berkovich, Aida Yakupova, Jonathan Eskenazi, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Neuroscience Research|December 13, 2002
Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoidNoel G Carlson
CNS Drugs|June 1, 2006
Antioxidants in multiple sclerosis: do they have a role in therapy?Noel G Carlson, John W Rose
Expert Opinion on Medical Diagnostics|March 15, 2013
Clinical biomarkers in multiple sclerosisJohn W Rose, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Vitamin D as a clinical biomarker in multiple sclerosisNoel G Carlson, John W Rose
Annals of Neurology|May 24, 2020
CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar DegenerationJohn E Greenlee, Noel G Carlson
Seminars in Neurology|July 17, 2018
Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and ImmunopathologyJon P Williams, Noel G Carlson, John E Greenlee
Current Treatment Options in Neurology|April 15, 2009
Monoclonal antibody treatments for multiple sclerosisJohn W Rose, John F Foley, Noel G Carlson
Expert Opinion on Medical Diagnostics|March 14, 2013
Optical coherence tomography as a biomarker in multiple sclerosisAnette Simble Fjeldstad, Noel G Carlson, John W Rose
American Journal of Physiology. Renal Physiology|April 21, 2005
P2Y2 receptor-mediated release of prostaglandin E2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD functionRujia Sun, Noel G Carlson, Andrew C Hemmert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2021
Improvement of Comorbid Psoriasis in Patients With MS Treated With NatalizumabRegina Berkovich, Aida Yakupova, Jonathan Eskenazi, et al.
Pageof 5